| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |